Word

TRIVENI

Status

Pending

Status Code

661

Status Date

Wednesday, May 29, 2024

Serial Number

97810745

Mark Type

4

Filing Date

Friday, February 24, 2023

Trademark Owner History

TRIVENI BIO, INC. - 1st New Owner Before Publication
Amagma, Inc. - Original Applicant

Classifications

5 Pharmaceutical, therapeutic and biopharmaceutical agents for treatment of immunological and inflammatory disorders; pharmaceutical, therapeutic and biopharmaceutical preparations and substances; biological preparations, namely, antibodies

42 Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; scientific research, namely, genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research, namely, DNA analysis and sequencing services for scientific and research purposes; scientific research, development and scientific research consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics, and microbiomics; software as a service (SaaS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics

Trademark Events

Mar 15, 2023

New Application Office Supplied Data Entered

Nov 25, 2023

Assigned To Examiner

Nov 30, 2023

Non-Final Action Written

Nov 30, 2023

Non-Final Action E-Mailed

Nov 30, 2023

Notification Of Non-Final Action E-Mailed

Jan 5, 2024

Application Extension Granted/Receipt Provided

Jan 5, 2024

Application Extension To Response Period - Received

Jan 17, 2024

Automatic Update Of Assignment Of Ownership

May 29, 2024

Teas/Email Correspondence Entered

May 29, 2024

Correspondence Received In Law Office

May 29, 2024

Teas Response To Office Action Received